Eric Lefkofsky Empowers Physician’s to treat Cancer with Tempus

Eric Paul Lefkofsky (www.lefkofsky.com/) is an entrepreneur from Southfield, Michigan with a determination to succeed. After attending the Univeraity of Michigan and graduating with honors in 1991, he attended the Univeraity of Michigan Law School and graduated in 1993 with his Muris Doctor. He persevered through many business ventures on his pathway to success and has a current role as founder and CEO of Tempus.

He is the co-founder of companies like Groupon, Echo Global Logistics, InnerWorkings, Mediaocean, and Uptake. Most recently, Lefkofsky co-founded Tempus in 2016 and is currently CEO of the company.

After graduating law school, Lefkofsky and a friend from college bought an apparel company, Brandon Apparel, with money they borrowed from family. The two went on to create Starbelly in 1999. Starbelly was an Internet company that sold promotional items. In 2000, Halo Industries bought the company, and Lefkofsky was hired as CEO. The company soon went bankrupt and faced many lawsuits, but they were all resolved. This didn’t prevent or stop Lefkofsky in any way.

In 2001, Eric Lefkofsky co-founded InnerWorkings to service print orders for companies. In 2005, he went on and started Echo Global Logistics. This was far from the end for Lefkofsky. In 2006, he did it again with the MediaBank, which provides customers with planning, buying, and accounting software.

Then in 2007, he provided capital to fund ThePoint.com. This online collective action website later changed its name to Groupon.com. In 2010, it was Lightbank, a firm designated with starting new companies in Chicago. In 2014, it was an analytic company, Uptake, LLC. Now, Lefkofsky is on to his new venture, Tempus.

This Bizjournals article discusses how Tempus is a technology company providing physicians the ability to provide personalized cancer care to patients. Physicians have the capability through Tempus’s innovative interactive analytical and machine learning platform to deliver cancer care that is focused and well-informed. Molecular profiles and genomic data is collected for analyzing. Physicians can then analyze a profile that is similar to their patient’s data to make the best decision possible for this patient. Each patient, each tumor is treated individually using the information that is stored in an easy accessible location.

The genomic sequencing services, analytical process of molecular and therapeutic data is unique in its ability to allow doctors to make split second decisions based on data. The data allows patients to receive the best possible treatment based on treatment records of patients in the past.

Tempus has taken cancer treatment to a new level. Tempus’s doesn’t simply store the data, it also produces a report that is detailed about the patient’s current cancer state and additional information that will assist with generating an effective plan for treatment. The standard of cancer care has just been amplified.